Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth H Mayer

Showing results (121-130 of 1,106) with videos related to

Pageof 111
Sort By:
Future Virology|September 4, 2010
How HIV treatment could result in effective preventionKartik K Venkatesh, Mark N Lurie, Kenneth H Mayer
Public Health Reports (Washington, D.C. : 1974)|June 15, 2004
Development of guidelines on nonoccupational HIV postexposure prophylaxis for the state of Rhode IslandRoland C Merchant, Kenneth H Mayer, Carol A Browning
Open Forum Infectious Diseases|October 14, 2017
Top Questions in ID: Pre-exposure Prophylaxis for HIVDouglas S Krakower, Stephanie E Cohen, Kenneth H Mayer
Medicine and Health, Rhode Island|October 16, 2002
Nonoccupational HIV post-exposure prophylaxis: guidelines for Rhode Island from the Brown University AIDS Program and the RI Department of HealthRoland C Merchant, Kenneth H Mayer, Carol A Browning
Plos Medicine|January 11, 2018
Sexually transmitted infections in the era of antiretroviral-based HIV prevention: Priorities for discovery research, implementation science, and community involvementJeanne M Marrazzo, Julia C Dombrowski, Kenneth H Mayer
The Lancet. HIV|March 4, 2021
Prioritising pleasure and correcting misinformation in the era of U=USarah K Calabrese, Kenneth H Mayer, Julia L Marcus
Annals of Internal Medicine|May 9, 2020
Sexual Health in the SARS-CoV-2 EraJack L Turban, Alex S Keuroghlian, Kenneth H Mayer
Journal of Acquired Immune Deficiency Syndromes (1999)|January 24, 2012
Raltegravir, tenofovir DF, and emtricitabine for postexposure prophylaxis to prevent the sexual transmission of HIV: safety, tolerability, and adherenceKenneth H Mayer, Matthew J Mimiaga, Marcy Gelman, et al.
International Journal of STD & AIDS|July 4, 2008
HIV transmission transcends three generations: can we prevent secondary transmission in India?Kartik K Venkatesh, Lakshmi Prasad, Kenneth H Mayer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2015
Formulating the Future Research Agenda for Postexposure Prophylaxis for HIV: Methodological Challenges and Potential ApproachesNandi Siegfried, Rachel L Beanland, Nathan Ford, et al.
Pageof 111

Showing results (121-130 of 1,106) with videos related to

Sort By:
Pageof 111
Future Virology|September 4, 2010
How HIV treatment could result in effective preventionKartik K Venkatesh, Mark N Lurie, Kenneth H Mayer
Public Health Reports (Washington, D.C. : 1974)|June 15, 2004
Development of guidelines on nonoccupational HIV postexposure prophylaxis for the state of Rhode IslandRoland C Merchant, Kenneth H Mayer, Carol A Browning
Open Forum Infectious Diseases|October 14, 2017
Top Questions in ID: Pre-exposure Prophylaxis for HIVDouglas S Krakower, Stephanie E Cohen, Kenneth H Mayer
Medicine and Health, Rhode Island|October 16, 2002
Nonoccupational HIV post-exposure prophylaxis: guidelines for Rhode Island from the Brown University AIDS Program and the RI Department of HealthRoland C Merchant, Kenneth H Mayer, Carol A Browning
Plos Medicine|January 11, 2018
Sexually transmitted infections in the era of antiretroviral-based HIV prevention: Priorities for discovery research, implementation science, and community involvementJeanne M Marrazzo, Julia C Dombrowski, Kenneth H Mayer
The Lancet. HIV|March 4, 2021
Prioritising pleasure and correcting misinformation in the era of U=USarah K Calabrese, Kenneth H Mayer, Julia L Marcus
Annals of Internal Medicine|May 9, 2020
Sexual Health in the SARS-CoV-2 EraJack L Turban, Alex S Keuroghlian, Kenneth H Mayer
Journal of Acquired Immune Deficiency Syndromes (1999)|January 24, 2012
Raltegravir, tenofovir DF, and emtricitabine for postexposure prophylaxis to prevent the sexual transmission of HIV: safety, tolerability, and adherenceKenneth H Mayer, Matthew J Mimiaga, Marcy Gelman, et al.
International Journal of STD & AIDS|July 4, 2008
HIV transmission transcends three generations: can we prevent secondary transmission in India?Kartik K Venkatesh, Lakshmi Prasad, Kenneth H Mayer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2015
Formulating the Future Research Agenda for Postexposure Prophylaxis for HIV: Methodological Challenges and Potential ApproachesNandi Siegfried, Rachel L Beanland, Nathan Ford, et al.
Pageof 111